Clinical Trials Directory

Trials / Completed

CompletedNCT05042817

Effect of Intrathecal Morphine on Urinary Bladder Function and Recovery in Patients Having a Cesarean Delivery

Effect of Intrathecal Morphine on Urinary Bladder Function and Recovery in Patients Having a Cesarean Delivery - A Double-blind Randomized Clinical Trial

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
56 (actual)
Sponsor
University of Liege · Academic / Other
Sex
Female
Age
18 Years
Healthy volunteers
Not accepted

Summary

The enhanced recovery anesthesia concept has been widely adopted, including cesarean delivery. Modern obstetrical anesthesia aims to offer an experience to a patient undergoing a cesarean delivery similar to normal vaginal delivery in order to maximize postoperative comfort and facilitate bonding between the mother and her newborn. Therefore, early removal of the bladder catheter has been recommended. However, this is challenged by the administration of intrathecal morphine recommended to provide long-lasting postoperative analgesia after cesarean delivery.

Detailed description

This double-blind, randomized trial investigates the effects of intrathecal morphine on urinary dynamics in women undergoing CD under spinal anesthesia. The hypothesis is that the addition of intrathecal morphine (ITM) will delay micturition in women undergoing cesarean delivery. The primary outcome is the effect of ITM on urodynamics the difference in time to micturition. The secondary outcome is the need for bladder re-catheterization.

Conditions

Interventions

TypeNameDescription
DRUG100 mcg morphineThe effect of intrathecal morphine on vesical function and the need for bladder re-catheterization after a cesarean delivery
DRUG0.9% NaClNaCl 0.9%
DRUG50 mg prilocaine + 2.5 mcg sufentanil50 mg prilocaine + 2.5 mcg sufentanil
PROCEDUREbilateral transverse abdominal plane block20 mL of ropicavaine 0.375% on each side

Timeline

Start date
2021-10-01
Primary completion
2022-03-31
Completion
2022-12-31
First posted
2021-09-13
Last updated
2023-03-20

Locations

1 site across 1 country: Belgium

Source: ClinicalTrials.gov record NCT05042817. Inclusion in this directory is not an endorsement.